Tactile Systems Technology (TCMD)
(Delayed Data from NSDQ)
$13.20 USD
-0.19 (-1.42%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $13.21 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.20 USD
-0.19 (-1.42%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $13.21 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Zacks News
Earnings Preview: Tactile Systems Technology (TCMD) Q2 Earnings Expected to Decline
by Zacks Equity Research
Tactile Systems Technology (TCMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -250.00% and 0.07%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Tactile Systems Technology (TCMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tactile Systems Technology (TCMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tactile Systems Technology (TCMD) Q4 Earnings Miss Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -4.35% and 1.72%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Tactile Systems Technology has been struggling lately, but the selling pressure may be coming to an end soon.
Tactile Systems Technology (TCMD) Q3 Earnings Match Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 0.00% and 9.53%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Tactile Systems Technology (TCMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IART vs. TCMD: Which Stock Is the Better Value Option?
by Zacks Equity Research
IART vs. TCMD: Which Stock Is the Better Value Option?
Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 180.00% and 6.96%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Tactile Systems Technology (TCMD) Q2 Earnings Expected to Decline
by Zacks Equity Research
Tactile Systems Technology (TCMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HOLX vs. TCMD: Which Stock Is the Better Value Option?
by Zacks Equity Research
HOLX vs. TCMD: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Willscot, Square, Martin Marietta, NetEase and Tactile
by Zacks Equity Research
Zacks.com featured highlights include: Willscot, Square, Martin Marietta, NetEase and Tactile
In Pursuit of an Earnings Beat? Play These Top 5 Stocks
by Sanghamitra Saha
These top-ranked stocks may surpass bottom-line estimates in their next release.
Veracyte (VCYT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Veracyte (VCYT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: Twitter, ServiceNow, Fortinet, Tactile Systems and Navigant Consulting
by Zacks Equity Research
Zacks.com featured highlights include: Twitter, ServiceNow, Fortinet, Tactile Systems and Navigant Consulting
5 Top Stocks Backed by Earnings Beat Potential
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next release.
Zacks.com featured highlights include: IAC/InterActiveCorp, Tactile Systems Technology, Martin Marietta Materials, Fortinet and Intuit
by Zacks Equity Research
Zacks.com featured highlights include: IAC/InterActiveCorp, Tactile Systems Technology, Martin Marietta Materials, Fortinet and Intuit
These 5 Top Stocks May Surprise You With an Earnings Beat
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases.
Tactile Systems Technology (TCMD) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 166.67% and 14.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now
by Zacks Equity Research
Strong prospects in emerging markets provide DENTSPLY (XRAY) a competitive edge in the MedTech space.
AngioDynamics' (ANGO) Q3 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Despite strength in the VIT business, AngioDynamics (ANGO) exited third-quarter fiscal 2019 on a tepid note, with both earnings and revenues missing estimates.
Glaukos (GKOS) Banks on Solid Pipeline Amid Stiff Competition
by Zacks Equity Research
Glaukos' (GKOS) strong pipeline is indicative of brighter prospects ahead. However, cutthroat competition in the medical-device industry is worrisome.
AngioDynamics Gets FDA Nod to Begin NanoKnife DIRECT Study
by Zacks Equity Research
AngioDynamics' (ANGO) launches AngioDIRECT.com for enrolling participants as part of the DIRECT clinical study.
Zacks.com featured expert Kevin Matras highlights: Columbia Sportswear, Tactile Systems Technology, Wright Medical, Carbonite and Palo Alto Networks
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Columbia Sportswear, Tactile Systems Technology, Wright Medical, Carbonite and Palo Alto Networks
Play Potential Earnings Beat With These 5 Top Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next release.